Previous close | 25.49 |
Open | 25.97 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 25.58 - 26.36 |
52-week range | 14.85 - 54.13 |
Volume | |
Avg. volume | 999,522 |
Market cap | 1.865B |
Beta (5Y monthly) | 1.11 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Unlike a lot of tech investors, Cathie Wood is super bullish on biotechnology. Here are three of her picks that these Motley Fool contributors love.
Veracyte (VCYT) delivered earnings and revenue surprises of 38.10% and 8.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Veracyte appears to be an intriguing pick for growth investors to compound their wealth over the long run.